Clinical trial · Interventional
Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-Chemotherapy
Comparison of Weight Loss Among Early Stage Breast Cancer Patients Post Chemotherapy: Nutrition Education in Combination With Weight Loss Acupuncture Vs. Nutrition Education Alone
NCT02081612CI-TRIAL-00039587completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study looks at the benefit of adding acupuncture to nutrition education for weight loss in women with early stage breast cancer post-chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture | Procedure | — | UNRESOLVED |
| Nutrition Education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Nutrition Education
- description
- Educational weight management group sessions alone
- interventionNames
- Behavioral: Nutrition Education
- type
- ACTIVE_COMPARATOR
- label
- Nutrition Education Plus Acupuncture
- description
- Educational weight management group sessions in addition to weight loss acupuncture
- interventionNames
- Behavioral: Nutrition Education
- Procedure: Acupuncture
Primary outcomes (1)
- measure
- Weight Loss
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Woman with a diagnosis of breast cancer, stage I, II, or III * Age ≥ 18 * ECOG performance status ≤ 1 * Received treatment for breast cancer, and treatment must have been completed at least 2 weeks prior to enrollment in trial, but no longer than 1 year post-treatment. * BMI ≥ 30 * Adequate bone marrow and organ function as determined by the consenting/enrolling investigator * Signed informed consent * Any receptor status * Participant is willing and able to comply with the protocol for the duration of the study including undergoing treatment, scheduled visits, and examinations Exclusion Criteria: * Current chemotherapy or radiation therapy. Participants in study may still be receiving hormone or Herceptin treatment. * Diagnosis of metastatic breast cancer * Participation in other diet-based weight loss programs (ie. Patient should not be currently enrolled in Weight Watchers, Jenny Craig, Nutrisystem, etc.) * Current use of commercial or natural/herbal weight loss supplements * Major surgery within 1 month of starting study program and patients must have recovered from any effects of major surgery * Other malignancies within the past three years except for adequately treated carcinoma of the cervix or basal or squamous cell carcinomas of the skin * Personal history of an eating disorder * Other serious, uncontrolled medical disorder, non-malignant systemic disease, or active, uncontrolled infection (including uncontrolled HIV, Hepatitis B or C), or any psychiatric disorder that prohibits obtaining informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.